Global Electrophysiology Ablation Catheters Medical Device Pipeline Market Landscape Report 2021: Product Description, Licensing and Collaboration Details, and Development Activities

DUBLIN, 05 May 2022–(BUSINESS WIRE)–The report “Electrophysiology Ablation Catheters – Medical Devices Pipeline Product Landscape, 2021” has been added to ResearchAndMarkets.com’s offer.

“Electrophysiology Ablation Catheters – Medical Devices Pipeline Product Landscape, 2021” provides comprehensive information on the pipeline products of Electrophysiology Ablation Catheters with a comparative analysis of the products at different stages of development and information on the clinical studies underway.

An electrophysiological ablation catheter contains an electrode at one end that emits RF waves to destroy a small area of ​​heart tissue in the abnormal conduction pathway, blocking the further channeling of the impulses that cause the abnormal heart rhythm.

Domain

  • Comprehensive coverage of the electrophysiology ablation catheters in development

  • The report reviews details of key pipeline products, including product description, licensing and collaboration details, and other development activities

  • The report provides an overview of the key players involved in the development of electrophysiological ablation catheters and lists all of their pipeline projects

  • The coverage of pipeline products based on different development stages ranging from early development to approved/issued stage

  • The report provides key clinical research data from ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to buy:

  • Formulate key information, analysis and insights about competitors to improve R&D strategies

  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand major and diverse types of electrophysiology ablation catheters under development

  • Developing Market Entry and Expansion Strategies

  • Effectively plan mergers and acquisitions by identifying key players with the most promising pipeline

  • In-depth analysis of the current product development stage, territory and estimated launch date

Main topics covered:

1 Table of Contents

1.1 List of tables

1.2 List of figures

2 Introduction

2.1 Overview of Electrophysiological Ablation Catheters

3 products in development

3.1 Electrophysiology Ablation Catheters – Pipeline Products by Developmental Stage

3.2 Electrophysiology Ablation Catheters – Pipeline Products by Segment

3.3 Electrophysiology Ablation Catheters – Pipeline Products by Area

3.4 Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path

3.5 Electrophysiology Ablation Catheters – Pipeline Products at Estimated Approval Date

3.6 Electrophysiological Ablation Catheters – Ongoing Clinical Studies

4 Electrophysiology Ablation Catheters – Company Development Pipeline Products

4.1 Electrophysiology Ablation Catheter Companies – Pipeline Products by Stage of Development

4.2 Electrophysiology Ablation Catheters – Pipeline Products by Developmental Stage

5 Electrophysiology Ablation Catheters Companies and Product Overview

5.1 Ablacon Inc Company Overview

5.2 Acotec Scientific Co Ltd Company Overview

5.3 Overview of Apama Medical Inc Company

5.4 Biosense Webster Inc Company Overview

5.5 BioTex Inc Company Overview

5.6 Boston Scientific Corp Company Overview

5.7 CardioFocus Inc Company Overview

5.8 CardioNova Ltd Company Overview

5.9 CathEffects LLC Company Overview

5.10 CathRx Ltd Company Overview

5.11 Cibim Inc Company Overview

5.12 Columbia University Company Overview

5.13 Cordis Corp. Corporate Overview

5.14 CoreMap Inc Company Overview

5.15 CPSI Biotech Company Overview

5.16 CryoTherapeutics Gmbh Company Overview

5.17 Epicardial Technologies Inc (Inactive) Company Overview

5.18 Ethicon US LLC Company Overview

5.19 Eximo Medical Ltd Company Overview

5.20 FocusStart LLC Company Overview

5.21 Hansen Medical Inc (Inactive) Company Overview

5.22 Hyblate Medical Company Overview

5.23 Imricor Medical Systems Inc Company Overview

5.24 Interventional Imaging, Inc. Corporate overview

5.25 Iowa Approach Inc. Corporate overview

5.26 Maestro Heart SA Company overview

5.27 Medlumics SL Company Overview

5.28 Medtronic Plc Company Overview

5.29 MedWaves Inc Company Overview

5.30 MicroPort Scientific Corp Company Overview

5.31 Northwestern University Company Overview

5.32 Novasentis Inc Company Overview

5.33 S4 Medical Corp Company Overview

5.34 SCR, Inc. Corporate overview

5.35 Seattle Children’s Hospital Company Overview

5.36 Shanghai HeartCare Medical Technology Co Ltd Company Overview

5.37 Shanghai MicroPort EP MedTech Co Ltd Company Overview

5.38 St. Jude Medical LLC Company Overview

5.39 Stereotaxis Inc Company Overview

5.40 University of Arkansas at Little Rock Company Overview

5.41 University of Michigan Company Overview

5.42 University of Rochester Company Overview

5.43 University of Texas Medical Branch at Galveston Company Overview

5.44 Vanderbilt University Company Overview

5.45 Vimecon GmbH Company overview

5.46 Vivonics Inc Company Overview

5.47 Voyage Medical (Inactive) Company Overview

5.48 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Electrophysiology Ablation Catheters – Recent Developments

7 Appendix

For more information on this report, please visit https://www.researchandmarkets.com/r/3dued3

Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220505005596/en/

Contacts

ResearchAndMarkets.com
Laura Wood, senior press manager
press@researchandmarkets.com
For EST business hours, call 1-917-300-0470
For USA/CAN Toll Free Call 1-800-526-8630
For GMT office hours, please call +353-1-416-8900

Leave a Comment